TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $60,000 | +39.5% | 3,608 | -64.6% | 0.00% | – |
| Q2 2022 | $43,000 | -10.4% | 10,190 | +102.3% | 0.00% | – |
| Q1 2022 | $48,000 | -50.0% | 5,038 | 0.0% | 0.00% | – |
| Q4 2021 | $96,000 | -30.4% | 5,038 | +21.1% | 0.00% | – |
| Q3 2021 | $138,000 | +23.2% | 4,160 | +44.3% | 0.00% | – |
| Q2 2021 | $112,000 | -19.4% | 2,883 | 0.0% | 0.00% | – |
| Q1 2021 | $139,000 | +2.2% | 2,883 | +10.0% | 0.00% | – |
| Q4 2020 | $136,000 | +94.3% | 2,622 | 0.0% | 0.00% | – |
| Q3 2020 | $70,000 | +37.3% | 2,622 | 0.0% | 0.00% | – |
| Q2 2020 | $51,000 | +2450.0% | 2,622 | +424.4% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -99.7% | 500 | -99.3% | 0.00% | -100.0% |
| Q2 2018 | $889,000 | +19.8% | 67,601 | +29.4% | 0.00% | +100.0% |
| Q1 2018 | $742,000 | – | 52,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |